The Latest Breaking News from John Moore

Novavax hitched its wagon to the global coronavirus pandemic. Before most Americans truly grasped the scope of the danger, the small Maryland biotech startup had secured $1.6 billion in U.S. funding for its COVID-19 vaccine. Its moonshot goal: delivering 2 billion shots to the world by mid-2021.

The virus became the third leading cause of death in the U.S., and caused so many to die in the prime of life that the country experienced the biggest drop in life expectancy since World War II.

The Queensland government has defended an unexpected hike in land values in flood-hit areas, saying valuations take in data from previous flood events.

Assertions by pharmaceutical company executives have created pressure for scientists and politicians to take action

When Pfizer CEO Albert Bourla said March 13 that all Americans would need a second booster shot, it struck many COVID-19 experts as a self-serving remark without scientific merit. It also set off spasms of doubt over the country’s objectives in its fight against the coronavirus.

Burns told use of Scots language would alienate London readers in letter that forms part of University of Glasgow project